Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-glycoprotein inhibition effect on the pharmacokinetics of two tacrolimus formulations
2020-001655-41Phase 2Completed
- Sponsor
- CHU Rennes
- Start
- Jul 2020
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tacrolimus (2 arms), sponsored by CHU Rennes. Primary endpoint: Change in area under the curve of tacrolimus blood concentrations between 0 and 24h. Started Jul 2020; status: completed.
02
Drugs
tacrolimus
Beyond the preview
Go deeper on 2020-001655-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001655-41.